Pharmacokinetics of intravenous polymyxin B in critically ill patients.
about
Using an Adenosine Triphosphate Bioluminescent Assay to Determine Effective Antibiotic Combinations against Carbapenem-Resistant Gram Negative Bacteria within 24 HoursEffective antibiotics in combination against extreme drug-resistant Pseudomonas aeruginosa with decreased susceptibility to polymyxin BIn-vitro activity of polymyxin B, rifampicin, tigecycline alone and in combination against carbapenem-resistant Acinetobacter baumannii in SingaporeThe Antibiotic Polymyxin B Impairs the Interactions between Shiga Toxins and Human Neutrophils.Teaching 'old' polymyxins new tricks: new-generation lipopeptides targeting gram-negative 'superbugs'.Colistin-induced nephrotoxicity in mice involves the mitochondrial, death receptor, and endoplasmic reticulum pathways.Colistin in the 21st century.Pharmacology of polymyxins: new insights into an 'old' class of antibiotics.Colistin and polymyxin B: peas in a pod, or chalk and cheese?Screening and biological activities of pedopeptins, novel inhibitors of LPS produced by soil bacteria.In vitro pharmacodynamics of various antibiotics in combination against extensively drug-resistant Klebsiella pneumoniae.Comparative effectiveness of aminoglycosides, polymyxin B, and tigecycline for clearance of carbapenem-resistant Klebsiella pneumoniae from urineHigh performance liquid chromatography-mass spectrometry assay for polymyxin B1 and B2 in human plasma.Host-dependent Induction of Transient Antibiotic Resistance: A Prelude to Treatment Failure.Clinical outcomes associated with polymyxin B dose in patients with bloodstream infections due to carbapenem-resistant Gram-negative rodsStructure-activity relationships for the binding of polymyxins with human α-1-acid glycoproteinSynergistic killing of NDM-producing MDR Klebsiella pneumoniae by two 'old' antibiotics-polymyxin B and chloramphenicol.Pharmacokinetics and pharmacodynamics of 'old' polymyxins: what is new?Pharmacokinetics and renal disposition of polymyxin B in an animal model.Human oligopeptide transporter 2 (PEPT2) mediates cellular uptake of polymyxins.Characterization of Polymyxin B Biodistribution and Disposition in an Animal ModelNephrotoxicity and efficacy assessment of polymyxin use in 92 transplant patientsOptimization of Polymyxin B in Combination with Doripenem To Combat Mutator Pseudomonas aeruginosaPolymyxin B Induces Apoptosis in Kidney Proximal Tubular Cells.Antimicrobial Activity and Toxicity of the Major Lipopeptide Components of Polymyxin B and Colistin: Last-line Antibiotics against Multidrug-Resistant Gram-negative BacteriaRisk factors for treatment failure of polymyxin B monotherapy for carbapenem-resistant Klebsiella pneumoniae infectionsPharmacokinetics and efficacy of liposomal polymyxin B in a murine pneumonia model.Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: resistance mechanisms and implications for therapy.Development and validation of a liquid chromatography-mass spectrometry assay for polymyxin B in bacterial growth media.Polymyxins: wisdom does not always come with age.Treatment for infections with carbapenem-resistant Enterobacteriaceae: what options do we still have?Optimum treatment strategies for carbapenem-resistant Acinetobacter baumannii bacteremia.Polymyxin B versus colistin: an update.Aerosolized Polymyxin B for Treatment of Respiratory Tract Infections: Determination of Pharmacokinetic-Pharmacodynamic Indices for Aerosolized Polymyxin B against Pseudomonas aeruginosa in a Mouse Lung Infection Model.Pharmacodynamic and pharmacokinetic considerations in the treatment of critically Ill patients infected with carbapenem-resistant Enterobacteriaceae.Recent advances and perspectives in the design and development of polymyxins.Clinical Pharmacokinetics and Pharmacodynamics of Colistin.Dosing and Pharmacokinetics of Polymyxin B in Patients with Renal Insufficiency.Comprehensive Guidance for Antibiotic Dosing in Obese Adults.Resurgence of Polymyxin B for MDR/XDR Gram-Negative Infections: An Overview of Current Evidence.
P2860
Q28391044-DB03ECB1-8A03-4C67-9FDC-7F9DCCBA55C8Q28478261-768A18F2-A55E-402C-B5D0-79EC38E0E29CQ28740868-D5E0503E-13D8-471E-96A6-04055D603BA4Q33428611-EE11A5A8-3C85-434D-8EC4-75372BDB32C7Q33662378-C33A54E1-D04B-4EA1-A0F9-4330060E1CC4Q33798324-ECB6E0BE-A3EA-4534-8912-FB57BC4C10A1Q33847509-6DA44071-A375-481C-9330-6F9AE154BF37Q34346283-7635E9FD-A78D-458C-B1A1-BA3BAC32DB54Q35008357-8AE9169A-BC55-4BA4-ACDB-521FAFD8221CQ35054823-5D8D591A-8A27-4B7E-86D5-46EAA39E8567Q35385713-D32DC5D4-8EEA-46BF-9E86-7AC15B1E7EADQ35598359-89430B3C-742C-4D98-8C6F-C12D03F147B0Q36089663-21ADB2B8-8B0C-4187-9260-A25CDBAF1F85Q36106267-D5ECAFAD-676E-4867-9850-A097D291715EQ36158501-887C6FD9-A5FD-4CB6-8B33-34D01B6FBC87Q36252997-82F7CBAA-C2B5-44C2-8275-39890883FD0DQ36255587-A09E9791-573E-4085-ACCA-B5976A5C59EEQ36335694-888B2C01-D714-4E23-9227-E84F2EABD23BQ36364194-F3B34D3C-475D-4E82-9545-45AC52552CF0Q36455352-87598313-81CA-4B17-8B2C-F92072E8CC8FQ36571918-EC101BCD-DE4A-480B-849A-11AD2B3D0B54Q36667079-D2471B29-EE09-41DF-AD56-68DECF7C326BQ36887819-52E652C2-4EFD-460C-BF52-1DCABFA5D007Q37124019-8DED1F64-9FEF-461C-8A3D-03D79D3367C9Q37165591-45CA87B0-1EEA-4003-823C-8F4266677B45Q37263364-21EF5879-FDAA-4EC2-960F-2276690C7316Q37360650-895D2125-0848-495F-B97E-F4A83560ABFFQ37656243-0FC5A725-DC8D-4148-9A4E-CF2B82DCBD2DQ37669021-FB2A50A9-1C86-46AA-9AB7-538B88164B04Q38111213-FFA2F511-2854-406D-8CDC-7C6CD1083D01Q38231648-3B67054B-2FD0-4D0E-A223-43BD26B74C15Q38416932-88C2CDAE-A187-46A7-87CB-633CF423751DQ38613051-5C286753-5802-4192-9B5F-99CAFEEBB714Q38755683-BA61EAA3-7629-44E6-92A2-975DE0A270ACQ38944862-F75B4385-D735-441C-8908-7FB85B1D7071Q39190865-9ECD9771-90E8-46CE-928B-83C2576766C5Q39333751-11855C24-8AD5-44B0-B45F-B3B87710009AQ40035349-06C47331-2B38-4202-BBD9-8741AA18655CQ40067964-1AB9A946-38C7-4B74-9F23-D5752A17079BQ40111993-18339A3A-5689-4270-8B65-721D3C9B4F5E
P2860
Pharmacokinetics of intravenous polymyxin B in critically ill patients.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Pharmacokinetics of intravenous polymyxin B in critically ill patients.
@en
Pharmacokinetics of intravenous polymyxin B in critically ill patients.
@nl
type
label
Pharmacokinetics of intravenous polymyxin B in critically ill patients.
@en
Pharmacokinetics of intravenous polymyxin B in critically ill patients.
@nl
prefLabel
Pharmacokinetics of intravenous polymyxin B in critically ill patients.
@en
Pharmacokinetics of intravenous polymyxin B in critically ill patients.
@nl
P2093
P2860
P50
P356
P1476
Pharmacokinetics of intravenous polymyxin B in critically ill patients
@en
P2093
Afonso L Barth
Alexandre P Zavascki
Fabiano Ramos
Guoying Cao
Larissa Lutz
Luciano Z Goldani
Silvana V Superti
P2860
P304
P356
10.1086/592577
P407
P577
2008-11-01T00:00:00Z